Mantovani A, Petracca G, Beatrice G, Csermely A, Tilg H, Byrne CD, et al. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. Gut. 2022;71(4):778–88.

Article  PubMed  Google Scholar 

Tamaki N, Kimura T, Wakabayashi SI, Umemura T, Izumi N, Loomba R, et al. Cardiometabolic criteria as predictors and treatment targets of liver-related events and cardiovascular events in metabolic dysfunction-associated steatotic liver disease. Aliment Pharmacol Ther. 2024;60(8):1033–41.

Article  CAS  PubMed  Google Scholar 

Zhang P, Liu J, Lee A, Tsaur I, Ohira M, Duonget V, et al. IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis. Cell Metab. 2024;36(10):2341–2354.e6.

Article  CAS  PubMed  Google Scholar 

Campanella B, Onor M, Lomonaco T, Benedetti E, Bramanti E. HS-SPME-GC-MS approach for the analysis of volatile salivary metabolites and application in a case study for the indirect assessment of gut microbiota. Anal Bioanal Chem. 2019;411(28):7551–62.

Article  PubMed  Google Scholar 

Donnarumma D, Arena A, Trovato E, Rigano F, Zoccali M, Mondello L. A miniaturized comprehensive approach for total lipidome analysis and vitamin D metabolite quantification in human serum. Anal Bioanal Chem. 2023;415(18):4579–90.

Article  CAS  PubMed  Google Scholar 

Zhang J, Wang S, Xu L, Zhang Q, Shang Z, Zhang Y. Multiple perspectives of Qingkailing injection-fraction-single compound in revealing the hepatotoxicity of baicalin and hyodeoxycholic acid. J Ethnopharmacol. 2018;215:147–55.

Article  CAS  PubMed  Google Scholar 

Wu J, Cai K, Chen Z, Hou W, Wang Q, Chen H, et al. Identification and screening of potential anti-pneumonia active ingredients and targets of Qing-Kai-Ling oral liquid via UHPLC-Q-Exactive Orbitrap mass spectrometry based on data post-processing. J Chromatogr A. 2024;1736: 465391.

Article  CAS  PubMed  Google Scholar 

Chen H, Li S, Pan B, Liu K, Yu H, Ma C, et al. Qing-Kai-Ling oral liquid alleviated pneumonia via regulation of intestinal flora and metabolites in rats. Front Microbiol. 2023;14:1194401.

Article  PubMed  PubMed Central  Google Scholar 

Zhang HY, Hu P, Luo GA, Liang Q, Wang Y, Yan S, et al. Screening and identification of multi-component in Qingkailing injection using combination of liquid chromatography/time-of-flight mass spectrometry and liquid chromatography/ion trap mass spectrometry. Anal Chim Acta. 2006;577(2):190–200.

Article  CAS  PubMed  Google Scholar 

Song Q, Zhang X, Liu W, Liang W, Zhou Y, Dinget Y, et al. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma. J Hepatol. 2023;79(6):1352–65.

Article  CAS  PubMed  Google Scholar 

Wu L, Xing L, Zou Y, Wang Z, Gou Y, Zhang L, et al. UPLC-QTOF-MS based comparison of rotundic acid metabolic profiles in normal and NAFLD rats. Metabolites. 2022;13(1):38.

Article  PubMed  PubMed Central  Google Scholar 

Shi J, Zhou J, Ma H, Guo H, Ni Z, Duan J, et al. An in vitro metabolomics approach to identify hepatotoxicity biomarkers in human L02 liver cells treated with pekinenal, a natural compound. Anal Bioanal Chem. 2016;408(5):1413–24.

Article  CAS  PubMed  Google Scholar 

Iannone V, Babu AF, Lok J, Gómez-Gallego C, D’Auria G, Vazquez-Uribe R, et al. Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model. Mol Metab. 2023;78: 101823.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li H, Niu L, Wang M, Liu C, Wang Y, Su Y, et al. Mechanism investigation of anti-NAFLD of Shugan Yipi Granule based on network pharmacology analysis and experimental verification. Heliyon. 2024;10(15): e35491.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan Y, Huang Z, Liu Y, Li X, Stalin A, Fan X, et al. Integrated serum pharmacochemistry, 16S rRNA sequencing and metabolomics to reveal the material basis and mechanism of Yinzhihuang granule against non-alcoholic fatty liver disease. J Ethnopharmacol. 2024;318(Pt A): 116822.

Article  PubMed  Google Scholar 

Zhang C, Xu R, Wang X, Sun L, Mo P, et al. Comprehensive transcriptomics and metabolomics analyses reveal that hyperhomocysteinemia is a high risk factor for coronary artery disease in a Chinese obese population aged 40–65: a prospective cross-sectional study. Cardiovasc Diabetol. 2023;22(1):219.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Zhang S, Deng H, Chen A, Chai L. Lead and copper led to the dysregulation of bile acid homeostasis by impairing intestinal absorption in Bufo gargarizans larvae: an integrated metabolomics and transcriptomics approach. Sci Total Environ. 2023;855: 159031.

Article  CAS  PubMed  Google Scholar 

Kiessling P, Kuppe C. Spatial multi-omics: novel tools to study the complexity of cardiovascular diseases. Genome Med. 2024;16(1):14.

Article  PubMed  PubMed Central  Google Scholar 

Xiao Y, Bi M, Guo H, Li M. Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis. EBioMedicine. 2022;79: 104001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Long J, Dai W, Zheng Y, Zhao S. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Mol Med. 2019;25(1):26.

Article  PubMed  PubMed Central  Google Scholar 

Oduro PK, Zheng X, Wei J, Yang Y, Wang Y, Zhang H, et al. The cGAS-STING signaling in cardiovascular and metabolic diseases: future novel target option for pharmacotherapy. Acta Pharm Sin B. 2022;12(1):50–75.

Article  CAS  PubMed  Google Scholar 

Hartung NM, Mainka M, Pfaff R, Kuhn M, Biernacki S, Zinnert L, et al. Development of a quantitative proteomics approach for cyclooxygenases and lipoxygenases in parallel to quantitative oxylipin analysis allowing the comprehensive investigation of the arachidonic acid cascade. Anal Bioanal Chem. 2023;415(5):913–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olaniru OE, Kadolsky U, Kannambath S, Vaikkinen H, Fung K, Dhami P, et al. Single-cell transcriptomic and spatial landscapes of the developing human pancreas. Cell Metab. 2023;35(1):184–199.e5.

Article  CAS  PubMed  Google Scholar 

Jiang P, Zeng Y, Yang W, Li L, Zhou L, Xiao L, et al. The effects of Fc fusion protein glucagon-like peptide-1 and glucagon dual receptor agonist with different receptor selectivity in vivo studies. Biomed Pharmacother. 2024;174: 116485.

Article  CAS  PubMed  Google Scholar 

Wang X, Lin H, Gu Y. Multiple roles of dihomo-γ-linolenic acid against proliferation diseases. Lipids Health Dis. 2012;11:25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schlueter RJ, Al-Akwaa FM, Benny PA, Gurary A, Xie G, Jia W, et al. Prepregnant obesity of mothers in a multiethnic cohort is associated with cord blood metabolomic changes in offspring. J Proteome Res. 2020;19(4):1361–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Wang T, Liu P, Yang F, Wang X, Zheng W, et al. Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food Funct. 2021;12(9):3898–918.

Article  CAS  PubMed  Google Scholar 

Xu L, Yin L, Qi Y, Tan X, Gao M, Peng J. 3D disorganization and rearrangement of genome provide insights into pathogenesis of NAFLD by integrated Hi-C, Nanopore, and RNA sequencing. Acta Pharm Sin B. 2021;11(10):3150–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arai T, Tanaka M, Goda N. HIF-1-dependent lipin1 induction prevents excessive lipid accumulation in choline-deficient diet-induced fatty liver. Sci Rep. 2018;8(1):14230.